Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

High Court's Med Mal Ruling Won't Spark Rise In Suits No Photo Available

Y. Peter Kang

The U.S. Supreme Court's recent ruling that a Delaware medical malpractice statute can't be enforced in federal court won't cause a no... (more story)

Justices To Clarify What's Fair Game With 'Skinny Labels' No Photo Available

Ryan Davis

A new U.S. Supreme Court patent case that will require the justices to spell out what generic-drug makers can say when marketing drugs... (more story)

What JPM Tells Us About Healthcare Deals In 2026 No Photo Available

Yeji Jesse Lee

Coming out of one of the bellwether events for the healthcare industry, attorneys in the space are feeling pretty good about 2026.